dc.contributor.author | Majd, MH | |
dc.contributor.author | Barar, J | |
dc.contributor.author | Asgari, D | |
dc.contributor.author | Valizadeh, H | |
dc.contributor.author | Rashidi, MR | |
dc.contributor.author | Kafil, V | |
dc.contributor.author | Shahbazi, J | |
dc.contributor.author | Omidi, Y | |
dc.date.accessioned | 2018-08-26T09:37:35Z | |
dc.date.available | 2018-08-26T09:37:35Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58121 | |
dc.description.abstract | Purpose: To achieve simultaneous imaging and therapy potentials, targeted fluoromagnetic nanoparticles were synthesized and examined in human breast cancer MCF-7 cells. Methods: Fe3O4 nanoparticles (NPs) were synthesized through thermal decomposition of Fe(acac)3. Then, magnetic nanoparticles (MNPs) modified by dopamine-poly ethylene glycol (PEG)-NH2; finally, half equivalent fluorescein isothiocyanate (FITC) and half equivalent folic acid were conjugated to one equivalent of it. The presence of Fe3O4-DPA-PEG-FA/FITC in the folate receptor (FR) positive MCF-7 cells was determined via fluorescent microscopy to monitor the cellular interaction of MNPs. Results: FT-IR spectra of final compound confirmed existence of fluorescein on folic acid grafted MNPs. The Fe3O4-DPA-PEG-FA/FITC NPs, which displayed a size rang about 30-35 nm using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), were able to actively recognize the FR-positive MCF-7 cells, but not the FR-negative A549 cells. Conclusion: The uniform nano-sized Fe3O4-DPA-PEG-FA/FITC NPs displayed great potential as theranostics and can be used for targeted imaging of various tumors that overexpress FR. ط¢آ© 2013 by Tabriz University of Medical Sciences. | |
dc.language.iso | English | |
dc.relation.ispartof | Advanced Pharmaceutical Bulletin | |
dc.subject | folate receptor | |
dc.subject | macrogol | |
dc.subject | magnetic nanoparticle | |
dc.subject | magnetite dopamine hydrobromide polyethylene glycol fluorescein isothiocyanate nanoconjugate | |
dc.subject | magnetite dopamine hydrobromide polyethylene glycol folic acid nanoconjugate | |
dc.subject | unclassified drug | |
dc.subject | article | |
dc.subject | breast cancer | |
dc.subject | cell interaction | |
dc.subject | cell strain MCF 7 | |
dc.subject | conjugation | |
dc.subject | decomposition | |
dc.subject | flow cytometry | |
dc.subject | fluorescence microscopy | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | image analysis | |
dc.subject | infrared spectroscopy | |
dc.subject | nanoimaging | |
dc.subject | scanning electron microscopy | |
dc.subject | transmission electron microscopy | |
dc.title | Targeted fluoromagnetic nanoparticles for imaging of breast cancer MCF-7 cells | |
dc.type | Article | |
dc.citation.volume | 3 | |
dc.citation.issue | 1 | |
dc.citation.spage | 189 | |
dc.citation.epage | 195 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.5681/apb.2013.031 | |